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Abstract
Some apicomplexan parasites have evolved distinct protein kinase families to modulate host cell
structure and function. Toxoplasma gondii rhoptry protein kinases and pseudokinases are involved
in virulence and modulation of host cell signalling. The proteome of Plasmodium falciparum
contains a family of putative kinases called FIKKs, some of which are exported to the host red
blood cell and might play a role in erythrocyte remodelling. In this review we will discuss kinases
known to be critical for host cell invasion, intracellular growth and egress, focusing on (i)
calcium-dependent protein kinases and (ii) the secreted kinases that are unique to Toxoplasma
(rhoptry protein kinases and pseudokinases) and Plasmodium (FIKKs).
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1. Introduction
Protein kinases mediate the transfer of phosphate groups from ATP to specific residues on
their target proteins, resulting in changes in the activity, stability, interactions with ligands
or localisation of the phosphorylated substrates. Kinases themselves are often similarly
regulated, and many of them function as signalling mediators that integrate upstream signals
in the form of second messengers, post translational modifications or binding of regulatory
proteins. It is therefore not surprising that many parasites have evolved distinct protein
kinase families with novel domain structures and biochemical features to regulate key
parasite-specific physiological processes that must be executed in a timely fashion during
development or in response to external stimuli and physiological cues from the host. As
signalling mediators, protein kinases are also well suited to function at the host–parasite
interface, where they can perturb host signalling pathways, activate dormant mechanisms in
the host cell, or disrupt the proper functioning of host proteins.
Both Toxoplasma and Plasmodium contain a family of calcium-dependent protein kinases
(CDPKs), whose occurrence is restricted to plants and Alveolates (the superphylum that
comprises the ciliates and apicomplexans), although trypanosomatids also possess kinases
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with an EF-hand calcium binding domain thought to be phylogenetically distinct from plant
and Alveolate CDPKs (Parsons et al., 2005). CDPKs have a domain structure consisting of a
calcium-binding domain fused to the kinase domain, such that kinase activity is stimulated
upon calcium binding. Studies of apicomplexan CDPKs have revealed a conserved
regulatory mechanism and highlighted the importance of calcium in regulating a number of
key physiological processes including host cell attachment and invasion, gliding motility
and parasite egress.
Toxoplasma gondii, a highly prevalent obligate intracellular protozoan parasite, seems to
rely for a large part on protein kinases and pseudo kinases to modify the host cell.
Toxoplasma is capable of infecting all nucleated cells of most warm-blooded animals. This
ability to establish a chronic infection in such a wide range of host species and cell types is
likely associated with its ability to modify many aspects of the host cell’s normal
physiology. It does this by secreting proteins from the rhoptry, a specialised secretory
organelle that is found only in apicomplexan parasites, directly into the host cytosol where
they can exert their function. Many rhoptry proteins have homology to kinases (Bradley et
al., 2005) and a large proportion of them are predicted to be pseudokinases (Peixoto et al.,
2010).
Malaria parasites (genus Plasmodium) also belong to the Apicomplexa, however, unlike
Toxoplasma, they have a very restricted range of host cells which they can invade and in
which they can replicate. After inoculation into the vertebrate host through the bite of an
infected mosquito, Plasmodium sporozoites must first invade hepatocytes, where they
undergo asexual proliferation (exoerythrocytic schizogony), generating several thousand
merozoites in the process. This strict dependence on hepatocytes for the pre-erythrocytic
stage of infection has, however, recently been challenged by in vivo observations of
Plasmodium berghei parasites developing in dermal and epidermal cells at the site of
inoculation and generating infective merozoites (Gueirard et al., 2010).
The only cell type permissive for invasion by Plasmodium merozoites is the erythrocyte (or
the reticulocyte in some instances). Invasion involves release of the contents of rhoptries and
micronemes (another type of specialised secretory organelle) and formation of a
parasitophorous vacuole (PV). The parasite causes considerable modifications to its host red
blood cell (RBC) that include the establishment of a complex trafficking system that
mediates translocation of parasite-encoded proteins to the RBC membrane skeleton and
surface (Cooke et al., 2004). In the case of Plasmodium falciparum, the most lethal of the
five species of malaria parasites that can infect humans, such proteins include components
of the so-called “knob” structures, through which parasite-infected RBCs adhere to vascular
endothelial cells, thereby significantly contributing to pathogenesis (Cooke et al., 2001).
There are no orthologs of the Toxoplasma rhoptry kinases in malaria parasites, however, the
P. falciparum kinome includes a family (20 members) of related kinase-like sequences
called FIKKs, due to the presence of a Phe-Ile-Lys-Lys motif they share in their kinase
domain (Ward et al., 2004). Most notably, 18 of the 20 fikk genes in P. falciparum are
predicted to encode fully functional kinases, 16 of which are predicted to be exported into
the host RBC (Schneider and Mercereau-Puijalon, 2005), and at least some of these enzymes
have been shown to be exported to the host RBC and to be associated with kinase activity
(Nunes et al., 2007, 2010).
Many of the Toxoplasma and Plasmodium kinases are related to kinases with known
functions in other eukaryotes and these will not be discussed in this review. Instead, we will
discuss in more detail, kinases from these parasites that are known to be critical for host cell
invasion, intracellular growth and parasite egress, focusing on (i) calcium-dependent protein
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kinases and (ii) the secreted kinases that are unique to Toxoplasma (ROPKs) and
Plasmodium (FIKKs).
2. Calcium-dependent regulation of invasion and egress
Calcium levels in T. gondii play key roles in regulating micronemal secretion-dependent
processes including host cell invasion, gliding motility and parasite egress (Nagamune et al.,
2008). Chelation of parasite intracellular calcium strongly inhibited both microneme release
and invasion of host cells, and this effect was partially reversed by raising intracellular
calcium using the ionophore A23187 (Carruthers et al., 1999). Additionally, evidence was
provided in this study for the requirement of a staurosporine-sensitive kinase activity in
regulating microneme discharge and for parasite invasion of host cells.
In Toxoplasma parasites, CDPKs were shown to be involved in host cell invasion through
the use of KT5926, an inhibitor of CDPKs in other systems (Kieschnick et al., 2001).
KT5926 blocks the motility of Toxoplasma tachyzoites and their attachment to host cells. In
vivo, the phosphorylation of only three parasite proteins was found to be blocked by
KT5926 (although there may be more), and in parasite extracts, a single KT5926-sensitive
protein kinase activity was detected. This activity was calcium-dependent but did not require
calmodulin. In a search for CDPKs in Toxoplasma, two members of the class of calcium-
dependent protein kinases (CDPKs) were detected. TgCDPK2 was only expressed at the
mRNA level in tachyzoites, with no detectable protein. TgCDPK1 protein present in
Toxoplasma tachyzoites cofractionated precisely with the peak of KT5926-sensitive protein
kinase activity. TgCDPK1 kinase activity was calcium-dependent but did not require
calmodulin or phospholipids. TgCDPK1 was found to be inhibited effectively by KT5926 at
concentrations that block parasite attachment to host cells. In vitro, TgCDPK1
phosphorylated three parasite proteins that migrated identically to the three KT5926-
sensitive phosphoproteins detected in vivo. These observations suggested a central role for
TgCDPK1 in regulating Toxoplasma motility and host cell invasion.
Subsequent chemical genetic and conditional knockout studies have shown that TgCDPK1
is the key transducer downstream of calcium fluxes in regulating these processes. Down-
regulation of TgCDPK1 expression severely impaired the secretion of micronemal proteins,
including adhesins needed for gliding motility (Lourido et al., 2010). The resulting defect in
gliding motility led to a significant decrease in host cell attachment and invasion.
Conditional knockout of TgCDPK1 also impaired parasite egress from host cells upon
induction with a calcium ionophore, with immotile parasites remaining within vacuoles.
This coincided with a defect in PV membrane (PVM) permeabilisation upon calcium
ionophore treatment, which likely resulted from impaired microneme secretion of the
perforin-like TgPLP1 protein (Lourido et al., 2010).
The canonical CDPK domain structure consists of an N-terminal protein kinase domain, that
is highly homologous to calmodulin-dependent kinases (CaMKs), and a C-terminal CDPK
activation domain (CAD) with four calcium-binding EF-hands (EF1 to EF4). A recent
biochemical and structural study of three apicomplexan CDPKs (TgCDPK1 and TgCDPK3
from T. gondii, and CpCDPK1 from Cryptosporidium parvum) has provided novel insights
into how these CDPKs are activated upon calcium binding by the CAD (Wernimont et al.,
2010). In in vitro assays, the kinase domain was activated by low micromolar calcium
concentrations. Calcium ‘in-out’ experiments suggested a partial irreversibility of this
calcium-dependent activation for TgCDPK1 and TgCDPK3, while CpCDPK1 activity was
reduced to basal level upon calcium removal. Actual mapping of potential auto-
phosphorylation sites may provide further insights into the reversibility of calcium-induced
activation of these CDPKs.
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Crystal structures have been solved for auto-inhibited (calcium-free) TgCDPK1 and
TgCDPK3 and for calcium-bound TgCDPK1 and CpCDPK1 (Wernimont et al., 2010). The
kinase domain adopts the bi-lobal structure characteristic of eukaryotic protein kinases
(ePKs), with a smaller N-terminal lobe (consisting mainly of β-strands) and a larger C-
terminal lobe (predominantly α-helical) connected together via a single stretch of
polypeptide (hinge region). A deep cleft formed between the two lobes contains the ATP
binding pocket and active site (Dar et al., 2005). In the calcium-free state, the CAD adopts
an overall dumbbell shape (resembling calmodulin in the absence of calcium) with two EF-
hands at each end of the dumbbell. The CAD packs against the front face of the kinase
domain, making contacts with both the N- and C-terminal lobes. The N-terminal helix of
EF1 extends into a long helix (CH1) that spans the length of the CAD and packs anti-
parallel along a second long helix (CH2). The N-terminus of CH1 connects directly with the
C-terminus of the kinase domain and packs against the kinase C-terminal lobe to block
substrate binding, analogous to the pseudo-substrate segment of CAMKII (Rosenberg et al.,
2005) (Fig. 1). Additional hydrophobic contacts with the N-and C-terminal lobes of the
kinase domain are made by EF2 and EF3, respectively. Calcium binding to all four EF hands
within the CAD causes conformational changes that expose hydrophobic surfaces and partial
unwinding and bending of the CH1 and CH2 helices. This leads to a dramatic rearrangement
of the CAD into a more compact structure. The calcium-bound CAD is also repositioned and
binds to the back face of the kinase domain, which induces a widening of the active site cleft
by altering the relative orientations of the two lobes of the kinase domain. Release of the
auto-inhibitory interactions between the CAD and kinase domain also allows repositioning
of the α-C helix and rearrangement of the P-loop and the activation loop regions into an
active conformation as seen in other kinase structures.
Apicomplexan CDPKs have no orthologs in humans and are most closely related to CDPKs
in plants. The essential functions of TgCDPK1 and the lack of orthologs in humans make it
an ideal target for novel anti-Toxoplasma therapeutic drugs. In particular, TgCDPK1 is
unique in having a glycine residue at the gatekeeper position, which is located at the rear of
the adenine binding pocket. ATP analogues with bulky substituents on the purine group can
be accommodated by analogue-sensitive kinases with small gatekeeper residues (with
glycine being the smallest), while kinases with larger gatekeeper residues cannot
accommodate these molecules (Bishop et al., 2000; Blethrow et al., 2004). Since few human
kinases contain a small gatekeeper residue (no known mammalian protein kinase has a
glycine gatekeeper), TgCDPK1 provides a promising analogue-sensitive target for bumped
kinase inhibitors (BKIs) that should have relatively little off-target effects on the human
kinome (Manning et al., 2002).
A number of BKIs have been developed for chemical genetic studies with engineered
analogue-sensitive kinase alleles in human cells. BKI analogues of 4-amino-1-tert-butyl-3-
phenylpyrazol-o[3,4-d]pyrimidine, with bulky aromatic substituents at the C3 position,
inhibit TgCDPK1 at sub-micromolar concentrations (Ojo et al., 2010; Sugi et al., 2010).
Consistent with conditional TgCDPK1 knockout studies, BKIs greatly reduced host cell
invasion by T. gondii and modestly affected intracellular growth. Parasites expressing an
analogue-resistant TgCDPK1, in which the gatekeeper glycine is mutated to methionine
(G128M), were significantly less sensitive to BKIs and thus validated TgCDPK1 as the
main BKI target in vivo. Crystal structures of calcium-free TgCDPK1 in complex with NA-
PP2 and NM-PP1 confirm the structural basis for the selectivity of these BKIs for a small
gatekeeper residue and will facilitate optimisation of these BKIs to further improve their
affinity and specificity (Ojo et al., 2010). Of the 114 functional kinases predicted in the T.
gondii genome, 12 are expected to be analogue-sensitive based on their gatekeeper residue
(Sugi et al., 2010). Thus, BKIs provide a promising approach to targeting key processes in
T. gondii with potentially fewer side effects on the host.
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That host cell invasion can be inhibited by staurosporine and involves calcium signalling has
also been known to be true for malaria parasites for 2–3 decades (Scheibel et al., 1987;
Ward et al., 1994). More recently, a role for a CDPK (PfCDPK1) in this process has been
revealed (Green et al., 2008; Kato et al., 2008), highlighting a definite level of unity in the
invasion strategies across the Apicomplexa. In addition to invasion, malaria parasites exploit
their repertoire of CDPKs to mediate several other developmental processes (see Billker et
al. (2009) for a comprehensive review). Briefly, these include male gametogenesis, shown in
the rodent-infecting parasite P. berghei to be dependent on PbCDPK4 (Billker et al., 2004);
gliding of ookinetes, the motile form that escapes the mosquito midgut during infection of
the insect vector, a process blocked in P. berghei parasites lacking PbCDPK3 (Ishino et al.,
2006); and switching of parasite behaviour from cell traversal to cell invasion at the early
stage of liver infection by P. berghei sporozoites, which requires PbCDPK6 (Coppi et al.,
2007). There is unity across the Apicomplexa not only with respect to the involvement of
CDPKs in invasion, but also in the mechanism of activation of these enzymes by calcium
(see above). A recent structural study of a Plasmodium CDPK (PfCDPK3) (Wernimont et
al., 2011) revealed that the residues mediating the largest conformational change following
calcium binding are the most conserved across the Apicomplexa, leading the authors to
propose that the mechanism described in the section above is conserved, presumably
throughout the CDPK family. Another interesting observation described in this report is that
although the CAD shares similar motifs and behaviour with calmodulin, there are sufficient
structural differences to consider the CDPK activation domain as a distinctive member of
the large EF-hand family of calcium-binding proteins. Given their key regulatory roles,
malaria CDPKs also present attractive drug targets. However, in contrast to the TgCDPKs,
the presence of non-glycine residues at the gatekeeper position in malaria CDPKs will
preclude the use of BKIs.
3. Host modification by secreted Plasmodium and Toxoplasma protein
(pseudo)kinases
Unlike most other ePKs, most members of the Plasmodium FIKK and Toxoplasma ROPK
families have signal peptides and are predicted to be secreted into the host cell. A recent
analysis of the completed genome sequence of the three most common strains of T. gondii
by Roos and colleagues found that the Toxoplasma kinome consists of 108 predicted active
kinases and 51 predicted pseudokinases (Peixoto et al., 2010) (Fig. 2). Compared with the
human kinome, which only contains ~10% pseudokinases (Manning et al., 2002), there is a
significant enrichment of pseudokinases in the Toxoplasma kinome. This is mainly due to an
expansion of the Toxoplasma-specific ROPK family, consisting of ~44 genes of which
approximately half are pseudokinases. It must be considered in this context that some
proteins thought to be pseudokinases on the basis of their sequence characteristics were
actually shown to be competent for phosphorylation (Kannan and Taylor, 2008; Taylor and
Kornev, 2010). This may be particularly relevant to sequences that are relatively distant
from classical ePKs, such as the ROPKs and FIKKs (see below).
Members of both the ROPK and FIKK families are characterised by a domain structure
consisting of an N-terminal signal peptide, a low complexity region and a conserved C-
terminal domain that adopts a canonical protein kinase fold. However, Toxoplasma ROP
kinase domains constitute a phylogenetically-distinct group from other ePKs, including
other apicomplexan kinases such as the malaria FIKK family. Proteins of the ROPK family
have roles in host cell modulation and virulence, although the molecular details of how most
of these proteins function are poorly understood. While some members of the ROPK family
have been shown to be active kinases (such as ROP16 (Yamamoto et al., 2009; Ong et al.,
2010), and ROP18 (El Hajj et al., 2007; Khan et al., 2009b)), others appear to be
pseudokinases with substitutions at key residues that abrogate catalytic activity (but see our
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comment above). The inability of ROP2 to bind ATP has also been reported and may be true
for other ROPK family pseudokinases (Labesse et al., 2009).
Twelve sequence motifs or sub-domains are highly conserved in protein kinase domains
(Hanks et al., 1988). Most of these sub-domains are clustered within the active site cleft
region and are important for ATP binding and catalysis, while others are crucial for
structural stability of the protein. The crystal structures of the ROP2 (Protein Data Bank
(PDB) accession codes 2W1Z and 3DZO) and ROP8 (3BYV) pseudokinase domains
revealed a number of structural features within their active site region that are incompatible
with catalysis and ATP binding (Labesse et al., 2009; Qiu et al., 2009). Substitution of the
VAIK motif with FEVH in both ROP2 and ROP8 results in loss of the critical lysine side
chain that normally coordinates the α- and β-phosphates of ATP, however, WNK is an
example of a kinase that lacks this lysine residue but is nevertheless active, through
recruiting another residue to substitute for the missing one (Xu et al., 2000). Replacement of
the DFG motif with GFE alters the magnesium coordination geometry, while substitution of
the HRD motif with HTY results in replacement of the catalytic base (asparagine) with
tyrosine.
3.1. Cellular destination of Toxoplasma rhoptry kinases
Although it is now well established that upon invasion Toxoplasma secretes the contents of
its rhoptries directly into the host cytosol, it is still unclear how these secreted proteins cross
the host membrane. Patch clamp experiments have shown a short spike in conductivity at the
time of invasion, which is suggestive of a break in the host membrane followed by resealing
(Suss-Toby et al., 1996). The Toxoplasma protein(s) that mediate this break remain
unknown. Recently, two Toxoplasma proteins with a Membrane Attack Complex/Perforin
(MACPF) domain were identified, one of which (TgPLP1) is necessary for egress, which
involves rupture of the PVM (Kafsack et al., 2009). TgPLP2 could be a candidate for
mediating the break in the host cell plasma membrane. Once rhoptry proteins are secreted
into the host cell cytosol they traffic to distinct cellular destinations based on other signals.
For example the rhoptry kinase ROP16 and the rhoptry protein phosphatase 2 C (PP2C-hn)
carry a nuclear localisation signal (NLS), which mediates their trafficking to the host
nucleus (Gilbert et al., 2007; Saeij et al., 2007). Many ROPKs traffic back to the PVM and it
was recently demonstrated that an arginine-rich amphipathic helix (RAH) domain is
necessary and sufficient for targeting ROPKs to the PVM (Reese and Boothroyd, 2009).
Transgenic expression of the RAH domain in host cells results in punctuate staining with
some overlap with the nuclear envelope. However, after Toxoplasma infection of those cells,
most of the staining relocated to the PVM (Reese and Boothroyd, 2009). The fact that the
RAH domain only interacts weakly with a variety of host membranes but strongly with the
PVM, which is derived from the host membrane, is puzzling. It has been suggested that the
RAH domain has no special affinity for a particular lipid composition but rather for negative
membrane curvature as the host nuclear envelope, which is negatively curved, associated
somewhat with RAH domain (Reese and Boothroyd, 2009). Indeed, it is well known that
Toxoplasma secretes proteins from its dense granules that are involved in the formation of a
tubulovesicular network consisting of elongated negatively curved nanotubules of 60–90 nm
in diameter, which are topologically cytosolic and connect with the vacuole-delimiting
membrane. Consistent with this, parasites without the dense granule protein GRA2, which
have an attenuated PVM tubular network, have attenuated recruitment of the RAH domain
to the PVM (Reese and Boothroyd, 2009). Thus, an important function of dense granule
proteins might be the formation of the extremely negatively curved tubular network, which
subsequently functions to attract rhoptry proteins with a RAH domain from the cytosolic
face of the PVM. Rhoptry proteins without a RAH domain or an NLS, such as Toxofilin,
stay in the host cell cytosol (Lodoen et al., 2010).
Lim et al. Page 6













3.2. Toxoplasma rhoptry kinase ROP16 modulates STAT signalling
Although it has been known for some time that Toxoplasma ROPKs can be secreted into the
host cytosol, their function has remained elusive. ROP2 was thought to mediate the
recruitment of mitochondria to the PVM, but a recent study showed that a ROP2 knockout
has no defect in mitochondrial recruitment (Pernas and Boothroyd, 2010). One of the first
ROPKs for which a particular function was ascribed was ROP16. Expression profiling of
human foreskin fibroblasts (HFFs) infected with types I, II or III parasites demonstrated that
these strains differ significantly in the modulation of host gene expression (Saeij et al.,
2007). To identify the Toxoplasma genomic loci involved, expression profiles of HFFs
infected with F1 progeny derived from crosses between types II and III were determined.
Quantitative trait locus (QTL) analysis, using host gene expression as the quantitative trait,
determined that the genotype at a locus on Toxoplasma chromosome VIIb correlated with
the strain-specific regulation of >1,000 human genes. Analyses for enrichment in functional
annotation of these genes implicated the STAT signalling pathway. Indeed HFFs infected
with type I or type III parasites have strong and sustained activation of STAT3 and STAT6
while the activation by type II is much weaker and only transient. A candidate gene
approach identified ROP16 as the Toxoplasma gene responsible for the strain-specific
activation of STAT3 and STAT6. ROP16 is secreted into the host cytosol upon infection and
subsequently traffics to the host nucleus. This nuclear translocation is dependent on an NLS
in ROP16 but its nuclear localisation was not important for the activation of STAT3 and
STAT6. Subsequently, these experiments were confirmed by other groups using a type I
strain where the ROP16 gene was removed by double homologous recombination
(Yamamoto et al., 2009; Ong et al., 2010). As expected, ROP16 kinase activity is necessary
for its effect on STAT3 and STAT6 (Yamamoto et al., 2009; Ong et al., 2010). Initially it
was predicted from sequence homology that ROP16 was a serine/threonine kinase and was
therefore unlikely to be responsible for the tyrosine phosphorylation of STAT3 and STAT6.
However, it has recently been shown that it can in fact directly phosphorylate these targets
(Yamamoto et al., 2009; Ong et al., 2010). One group showed that immunoprecipitated
ROP16 can phosphorylate Tyr705 of recombinant STAT3 and subsequent co-
immunoprecipitation experiments determined that the N-terminal region (amino acid 223–
303) of ROP16 is required for this interaction with STAT3. By constructing chimeras
between the types I and II ROP16 proteins, the difference in STAT activation by these two
alleles could be attributed to a single amino acid substitution; a conversion of serine to
leucine at position 503 also made type II ROP16 a potent activator of STAT3.
Similarly, Boothroyd and colleagues showed that ROP16 has intrinsic tyrosine kinase
activity as determined by phosphoamino acid analysis of auto-phosphorylated ROP16. In
vitro kinase assays with recombinant ROP16 and recombinant STAT6-GST as a substrate
also showed efficient phosphorylation of Tyr641 on STAT6 by wild-type but not K404N
(kinase-dead) recombinant ROP16. The pan-JAK inhibitor and the tyrosine kinase inhibitor
K-252a severely impaired the kinase activity of ROP16, providing further evidence that
ROP16 is a tyrosine kinase (Yamamoto et al., 2009; Ong et al., 2010). Thus, ROP16 can
directly phosphorylate Tyr705 and Tyr641 from STAT3 and STAT6, respectively. This
could explain why the up-regulation of the suppressor of cytokine signalling (SOCS) genes,
which normally down-regulate the STAT pathway (Dalpke et al., 2008), do not down-
regulate the STAT3/6 activation by ROP16 (Saeij et al., 2007). SOCS proteins bind to
phosphorylated tyrosine residues on Janus kinases (JAKs) and/or cytokine receptor subunits
through a central SH2 domain and subsequently mediate their degradation (Dalpke et al.,
2008). Because the JAKs and cytokine receptors are bypassed by the direct phosphorylation
of STAT3 and STAT6 by ROP16, the inhibitory function of SOCS proteins is abrogated. By
directly phosphorylating STAT3 Toxoplasma could mimic the effects of IL-10, which also
maintains constitutive activation of STAT3 because its receptor does not interact with the
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SOCS proteins (Yasukawa et al., 2003). IL-10 is a potent anti-inflammatory cytokine which
can down-regulate the production of IFN-γ, the main mediator of resistance to Toxoplasma.
The prediction would therefore be that ROP16 can enhance parasite virulence by
suppressing IFN-γ production.
Indeed, ROP16 was also identified as one of the loci involved in the difference in virulence
between types II and III (Saeij et al., 2006). However, addition of ROP16 from type I or type
III into a type II strain made it less virulent. Why type II + ROP16I/III parasites have reduced
virulence is currently unknown. Although ROP16I/III can lower the level of secretion of
IL-12 by macrophages infected with type II strains, which could lead to subsequent lower
induction of IFN-γ secretion, one would predict that this would lead to an enhanced and not
a reduced virulence phenotype.
A potential explanation for this apparent contradiction is emerging from our recent studies
showing that macrophages infected with type I or type III strains are converted into an
alternatively activated or M2 macrophage (Jensen et al., 2011). These M2 macrophages are
characterised by high level expression of arginase-I and several lectin receptors such as the
mannose receptor and macrophage galactose specific lectin. Type II infected macrophages
are converted into classically activated or M1 macrophages and secrete large amounts of
proinflammatory cytokines such as IL-12p70 and IL-23. Activation of STAT6 by ROP16 is
necessary to convert macrophages to the M2 phenotype, while the M1 phenotype is due to
the fact that the type II strains, but not the types I and III, activate NFκB, a phenotype due to
a new polymorphic dense granule protein GRA15 (Rosowski et al., 2011). Thus, it is
possible that one of the roles of ROP16 is to limit the inflammation induced by the strong
Th1 induction by Toxoplasma and the reduction of virulence of the II + ROP16I might be
due to reduced immune pathology. We have evidence that ROP16-mediated reduction of
type II virulence is especially pronounced in Th1-prone mice such as C57/BL6 (J. Saeij,
unpublished data). Alternatively, the high induction of the arginase enzyme by ROP16 could
deplete L-arginine, for which T. gondii is an auxotroph, and thereby inhibit Toxoplasma
growth (Butcher et al., 2011).
3.3. Toxoplasma rhoptry kinase ROP18
ROP18 was identified as a rhoptry kinase involved in virulence by two different groups
(Saeij et al., 2006; Taylor et al., 2006). Sibley and colleagues were interested in the genes
involved in the difference in virulence between the highly virulent type I strain (LD100 = 1)
and the avirulent type III strains (LD50 ~ 100,000) (Taylor et al., 2006). Boothroyd and
colleagues used the difference in virulence between types II (LD50 ~ 500) and III as the
basis for their studies (Saeij et al., 2006). Both groups used crosses between these strains to
generate F1 progeny which were subsequently injected into mice to determine their
virulence phenotypes. A genetic map was previously generated for Toxoplasma (Khan et al.,
2005) and this was used to determine which Toxoplasma loci correlated with virulence.
Interestingly, the only locus identified using the Ix-III cross F1 progeny was ROP18 and
indeed a type III strain expressing type I ROP18 (III + ROP18I) was as virulent as a wild-
type type I strain (Taylor et al., 2006). ROP18 kinase activity was necessary to confer
virulence as the type III expressing the type I kinase dead mutant was avirulent. The
difference in virulence between types II and III was more complicated and implicated five
different loci, one of which was ROP18. A type III strain expressing type II ROP18 (III +
ROP18II) became extremely virulent (LD50 ~ 5) (Saeij et al., 2006). The expression level of
ROP18 seems to be a key determinant in the strain-specific differences in virulence. Type III
strains have an extremely low level of ROP18 expression, probably due to an extra 2.1 kb
sequence 85 bp upstream of the ATG start codon while types I and II express ROP18 at a
high level (Saeij et al., 2006).
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Although both studies demonstrated that ROP18 is secreted into the host cytosol and
subsequently traffics back to the PVM, its substrate(s) remained unidentified. When ROP18
is over-expressed in host cells it also traffics to the PVM of invading parasites, showing that
it has a strong affinity for the PVM (El Hajj et al., 2007; Reese and Boothroyd, 2009). Like
many rhoptry proteins, ROP18 is proteolytically processed. It is initially present as a 60 kDa
protein but is subsequently processed to a 56 kDa protein. It contains the conserved S-Phe-
X-E consensus motif (Phe represents bulky hydrophobic residues and X is any amino acid)
for recognition by TgSUB2, a subtilisin-like serine proteinase (El Hajj et al., 2007). When
comparing the ROP18 genes from multiple strains it was noted that it is one of most
polymorphic proteins, with evidence for strong diversifying selection. For example, the
sequences of types I and II ROP18 are very different, with almost no synonymous changes
between the types I and II alleles. Currently there is no evidence for a different function of
the different ROP18 alleles, because quite diverse ROP18 alleles from several strains all
confer virulence to type III parasites when expressed in this avirulent strain (Khan et al.,
2009b). It is also unknown whether over-expression of the type III ROP18 itself would also
confer virulence. Comparison of the ROP18 genomic region between Toxoplasma and
Neospora caninum, a close relative of T. gondii, demonstrated that Neospora also has the
extra region in the promoter of its ROP18. Thus, the most parsimonious explanation is that
the ancestral ROP18 gene contained the extra sequence in its promoter, resulting in low
level expression and subsequently this region was deleted to give rise to the more recently
derived types I and II ROP18 alleles (Khan et al., 2009b). It was also hypothesized that
strains carrying the type I ROP18 allele might be more successful because more strains have
a ROP18 allele similar to the type I strain (Khan et al., 2009b); however this could also be
due to other strains being more similar to type I strains compared with type II strains.
3.3.1. Proposed regulatory mechanism of ROP18—Protein kinases display a diverse
array of regulatory mechanisms that exploit multiple ways of impeding or distorting the
binding of ATP, magnesium or protein substrates to prevent catalysis. This often involves a
distortion of the inter-lobe orientation, conformational change of the activation loop to block
ATP and/or substrate binding, or occlusion of the active site. Activation of the kinase
domain often involves phosphorylation (particularly of the activation loop), but may also
involve other mechanisms such as binding or dissociation of regulatory domains or subunits
(Huse and Kuriyan, 2002; Dar et al., 2005).
The ROP2 and ROP8 kinase domain crystal structures (PDB accession codes 3DZO and
3BYV) revealed a unique N-terminal subdomain that is conserved in other ROPK family
kinase domains and contains features that preclude ATP binding in two of the ROPK
pseudokinase structures determined. This ~40 residue N-terminal extension consists of an α-
helical segment (packed against the C-terminal lobe) connected via a short linker region to
an α-helix and β-strand packed against the N-terminal lobe. In both 3DZO and 3BYV, an
arginine side chain from the N-terminal subdomain linker region (Arg 219 in 3DZO and
Arg 228 in 3BYV) forms a salt bridge interaction with the side chain of Glu 284 in 3DZO
and Glu 293 in 3BYV. The glutamate and arginine side chains occupy the expected position
of the ATP adenine group. Based on a homology model of the ROP18 kinase domain (with
the ROP8 crystal structure as a template), a novel kinase regulatory mechanism was
proposed for ROP18, in which the N-terminal subdomain was predicted to impede ATP-
binding (as observed in 3DZO and 3BYV). Furthermore, phosphorylation at sites within and
near the ROP18 N-terminal subdomain was proposed to regulate this auto-inhibition (Qiu et
al., 2009).
Similar to other active protein kinases and in contrast to the ROP2 and ROP8 structures, the
modelled active site of ROP18 was free of bulky side chains that would preclude ATP
binding, with the exception of Gln 214 and Gln 216. The side chains of both residues were
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predicted to protrude into the ATP binding pocket from the N-terminal subdomain linker
region (analogous to Arg 219 in 3DZO and Arg 228 in 3BYV). Consistent with the
homology model, mutation of Gln 214 and Gln 216 to Ala resulted in a three to four fold
increase in in vitro auto-phosphorylation and phosphorylation of myelin basic protein by
recombinant ROP18 kinase domain. Activation was then suggested to involve a
displacement or conformational change of the N-terminal subdomain to move the side
chains of Gln 214 and Gln 216 out of the ATP binding pocket. ROP18 kinase domain
expressed in Escherichia coli was auto-phosphorylated on Ser 221 and Thr 229 (second
helix of the N-terminal subdomain), and on Thr 249 and Thr 251 (in contact with the N-
terminal subdomain β-strand). Mutation of these Ser and Thr residues to Ala, reduced in
vitro kinase activity by up to 90% (Qiu et al., 2009). It was therefore proposed that
phosphorylation of one or more of these Ser/Thr residues activated ROP18 by altering the
interaction of the N-terminal subdomain with the N-terminal lobe to shift the linker region
containing Gln 214 and Gln 216 away from the ATP binding pocket. However, several
aspects of this proposed auto-inhibitory mechanism require further investigation.
Comparison of the available crystal structures, suggests that loss of the salt bridge
interaction between the glutamate side chain within the adenine binding pocket (Glu 284 in
3DZO and Glu 293 in 3BYV) and the arginine side chain on the N-terminal subdomain
linker (Arg 219 in 3DZO and Arg 228 in 3BYV) displaces the N-terminal subdomain linker
away from the active site as can be seen in 2W1Z. Since this salt bridge interaction is also
not conserved in ROP18, it is unclear if the N-terminal subdomain linker in ROP18 adopts
the auto-inhibitory conformation as seen in 3DZO and 3BYV. The auto-phosphorylation
sites within the ROP18 N-terminal subdomain were mapped using recombinant protein, and
whether these sites are phosphorylated in vivo and even the extent to which these sites were
auto-phosphorylated in vitro were not reported. Kinase assays of recombinant ROP18
following phosphatase treatment were not presented, but may help to verify the importance
of auto-phosphorylation in activating ROP18. Given the importance of the N-terminal
subdomain to the proper folding of ROP18, it remains formally possible that the N-terminal
Ser/Thr to Ala mutants decreased kinase activity by destabilising ROP18 structure.
Conversely, the effect of phospho-mimicking mutations of these N-terminal Ser/Thr
residues to Asp or Glu on kinase activity were also not reported, but may provide a useful
alternative means to test the importance of these phosphorylation sites in activating ROP18.
3.3.2. What are the ROP18 substrates?—The effect of ROP18I on type III virulence
could be due to its effect on parasite growth; vacuoles with type III + ROP18I have on
average twice as many parasites at 40 h p.i. compared with vacuoles with wild-type type III
strain parasites (El Hajj et al., 2007). This effect of ROP18 on parasite growth seems to be
vacuole autonomous as only parasites in vacuoles of type III + ROP18I have a shorter
replication time even if they are next to a vacuole with a wild-type type III strain. Because
this result was obtained in HFFs, possible host targets for ROP18 should be present in non-
stimulated HFFs and are most likely present on the vacuole itself. Besides parasite proteins
such as rhoptry proteins and dense granule proteins, several host proteins have also been
described to relocalise to the PVM.
The most interesting potential substrates, at least in murine cells, would be the immunity-
related GTPases (IRGs). These small GTPases are related to dynamins but are highly
induced upon IFN-γ stimulation of cells and subsequently traffic to the PVM where they
mediate dynamin-like vesiculation and subsequent rupture of the PVM and eventually the
destruction of the parasite (Martens et al., 2005; Ling et al., 2006; Melzer et al., 2008). The
accumulation of IRGs on the parasite PVM is also a strain-specific phenotype; type I
vacuoles seem to resist high accumulation of these IRGs and type I vacuoles are resistant to
destruction, while types II and III vacuoles accumulate high levels of the IRGs and are
effectively destroyed by IFN-γ (Zhao et al., 2009a,b). To investigate whether ROP18 had a
Lim et al. Page 10













role in this strain-specific difference, the accumulation of IRGs on vacuoles of type III
infected cells was compared with vacuoles of type III + ROP18I but no difference in
accumulation of ROP18 was observed (Zhao et al., 2009a). Similarly, transfection of
ROP18I or ROP18II into IFN-γ-induced L929 fibroblasts had no effect on the accumulation
of IRGs on type II vacuoles (Khaminets et al., 2010).
In contrast to the above mentioned studies it was recently reported that ROP18I can bind to
and directly phosphorylate Irga6, Irgb6 and Irgb10 (Fentress et al., 2011; Steinfeldt et al.,
2011), thereby preventing their accumulation on the PVM. For Irga6 it was demonstrated
that ROP18 can phosphorylate two threonine residues in the switch I loop (T102 and T108)
(Steinfeldt et al., 2011), while Irgb6 was mainly phosphorylated on a single threonine
residue in its switch I loop (Fentress et al., 2011). Because these threonine residues are at the
catalytic interface that is essential for GTP-dependent active dimer formation, it is likely that
their phosphorylation inactivates the protein. Indeed, phospho-mimetic mutants of Irga6
were inefficiently loaded onto the PVM and could inhibit loading of wild-type Irga6
(Steinfeldt et al., 2011). Antibodies specific for pT102 and pT108 demonstrated that type I
vacuoles contained significant amounts of pT102 and pT108. Type II vacuoles did not
contain any pT102 but did contain pT108, although significantly less compared with type I
strains. Whether the phosphorylation of T108 is mediated by type II ROP18 remains to be
determined. The phosphorylation of Irgb6 is of particular interest as this is one of the first
IRGs recruited to the vacuole and it has been proposed to mediate the subsequent
recruitment of other IRGs. Knockdown of Irgb6 resulted in significantly less killing of
Toxoplasma by IFN-γ stimulated macrophages.
It was speculated that the difference between the studies reporting an effect of ROP18 and
studies reporting no effect (all studies were performed by the same two groups) was the
IFN-γ concentration; only at a low (<1 U/ml) IFN-γ concentration was an effect of ROP18I
expressed in type III on Irga6 loading on the vacuole detectable. This probably indicates that
other polymorphic parasite proteins play a role in resistance to the IRG system, because type
I strains can inhibit IRG loading even after stimulation of 200 U/ml IFN-γ. The specific cell
type used might also be important. Sibley and colleagues demonstrated that prevention of
IRG accumulation on vacuoles of parasites expressing ROP18I prevents the killing of
Toxoplasma by GR1+ inflammatory monocytes or IFN-γ stimulated macrophages (Fentress
et al., 2011).
That ROP18 is not the only factor responsible for reduced IRG loading might also explain
why type III + ROP18II are as virulent as type III + ROP18I, while the PVM of the type II
strain itself is efficiently coated by the IRGs. Possibly the type II strain lacks another
polymorphic Toxoplasma protein, present in both types I and III, that is necessary for
ROP18 activity in vivo or it could contain a protein that somehow blocks ROP18 activity.
Furthermore, it is unlikely that the IRGs are the only substrates for ROP18 because these
IRGs are not expressed in human cells or non-stimulated cells and the effect of ROP18 on
parasite growth was reported in un-stimulated HFFs. Based on the ability of bacterially-
expressed and re-folded ROP18 kinase to phosphorylate 70 kDa and 68 kDa proteins in
heat-inactivated parasite lysates, it has been suggested that ROP18 can also phosphorylate
parasite-derived proteins (El Hajj et al., 2007). It is possible that these proteins are in fact
ROP2, ROP8 or ROP18 itself, as bacterially-expressed versions of those proteins were also
shown to be phosphorylated by ROP18. However, whether these proteins are bona fide
substrates in an infected cell remains unknown.
A number of unbiased strategies may be pursued for the identification of substrates or
interactors of ROPK family active kinases and pseudokinases (Sopko and Andrews, 2008).
Engineering a kinase of interest (by mutation of its gatekeeper residue to Gly or Ala, see
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below) to accept ATPγS analogues containing bulky substituents, allows chemical tagging
of its direct substrates. Subsequent alkylation of the thiophosphate groups allows isolation of
the tagged substrates by a thiophosphate ester-specific antibody for identification by mass
spectrometry (Allen et al., 2007). Due to the cell impermeability of ATP analogues,
substrates must be thiophosphorylated in lysates, where the relative spatial organisation of
kinases and their substrates can be lost, potentially leading to false positives (Blethrow et al.,
2004). Additionally, not all kinases are compatible with gatekeeper mutations required for
analogue sensitivity and/or with thiophosphorylation. A potential problem for the
Toxoplasma kinome discussed earlier in the present review is the presence of a number of
endogenous analogue-sensitive kinases, such as TgCDPK1, that inherently have small
gatekeeper residues, which may further complicate this approach (Sugi et al., 2010). An
alternative method of kinase substrate identification utilises mass spectrometry to detect
changes in the abundance of phospho-sites due to the knockout of a kinase or treatment with
a specific small molecule inhibitor, if available (Sopko and Andrews, 2008). Due to the
effects on possible downstream kinases, substrates identified by this approach may not be
direct, although it may be possible to filter out such indirect “false positives” with
knowledge of the phosphorylation motif of the kinase of interest. The use of a positional-
scanning peptide array (Hutti et al., 2004) to define the substrate preference of ROP18 was
recently published (Fentress et al., 2011). Other approaches to identify kinase substrates that
are also amenable to identifying interactors of pseudokinases include yeast 2-hybrid and co-
purification of ligands/substrates with a tagged kinase or pseudokinase from cell lysates
(Sopko and Andrews, 2008). The sensitivity of yeast 2-hybrid can facilitate the detection of
transient kinase–substrate interactions, which may be stabilised by the use of a catalytically-
inactive kinase bait.
3.4. ROP5, a pseudokinase essential for Toxoplasma virulence
The analysis of virulence of the F1 progeny from II × III crosses identified a locus on
Toxoplasma chromosome XII as having the largest contribution to the strain-specific
differences in virulence. Interestingly, the avirulent type III strain contributed to the
enhanced virulence while the more virulent type II strain contained the avirulent locus (Saeij
et al., 2006).
It was recently demonstrated that the pseudokinase ROP5 is responsible for this difference
in virulence (Reese et al., 2011). Initially, a completely avirulent F1 progeny (S22, LD50 >1
× 106 para-sites) was complemented with a type I cosmid containing ROP5 and a four log
increase in virulence was noted. However, because the cosmid contained two other genes, a
refined analysis was needed. Therefore the ROP5 locus was deleted in a type I strain, and
surprisingly this strain was completely avirulent (LD50 >1 × 106) (Reese et al., 2011). The
ROP5 locus is quite complicated and it seems that type II strains contain 10 copies of ROP5,
type I: four copies and type III: six copies. These copies consist of at least three different
alleles for each strain, with the types I and III alleles being the most similar.
Complementation of the type I knockout with one allele increased virulence, while only
complementation with two or more alleles converted the virulence to wild-type virulence.
The crystal structure of the ROP5BI kinase domain showed a canonical protein kinase
domain fold and is highly similar to the crystal structures of the ROP2 and ROP8
pseudokinase domains (Reese and Boothroyd, 2011). However ROP5 was predicted to be
inactive due to the substitution of the Asp residue within the HRD motif (catalytic base)
with a basic residue (Lys or His depending on the ROP5 allele). Consistent with this, no
detectable kinase activity was reported for recombinant ROP5 protein in vitro. The ROP5
pseudoactive site is able to bind ATP and the crystal structure revealed a distorted ATP
binding mode, due to an unusual positioning of magnesium coordination sites. Comparison
of the ROP5BI pseudokinase domain crystal structures with and without ATP bound
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revealed no major conformational changes upon ATP binding. ROP5 is also not predicted to
be processed because it lacks the subtilisin cleavage motif. Sibley and colleagues recently
made a cross between a strain from types I and II and reported that a single QTL, containing
the ROP5 gene cluster, controls virulence difference between these strains (Behnke et al.,
2011). Indeed, through similar studies as described above they determined that ROP5
determines the differences in virulence between the types I and II. The fact that ROP18 did
not determine virulence differences between types I and II indicates that types I and II
ROP18 seem to be functionally equivalent. Although only a single QTL was identified, this
does not mean that other genes are not involved in determining virulence differences
between the types I and II. For example, some of the F1 progeny from the I×II cross contain
both the virulent ROP5 and ROP18 alleles but are not 100% lethal, indicating that other
genes must be involved (Behnke et al., 2011).
The mechanism underlying ROP5-mediated virulence is currently unknown. Restoration of
the catalytic base within the HRD motif by substitution of the basic residue in the ROP5AIII
allele with Asp resulted in significantly reduced virulence in mice. However the equivalent
substitution in the ROP5BI allele did not restore in vitro catalytic activity in recombinant
protein, and the basis for the reduced virulence conferred by the ROP5AIII R389D mutant is
unclear (Reese and Boothroyd, 2011). To compare the contribution of ROP5 to virulence
with that of ROP18, a ROP18 knockout strain was also created. Surprisingly, the type I
ROP18 knockout strain was as virulent as the wild-type strain and only a slight delay until
death was noted. This seems to contradict the important role of ROP18 in virulence that was
previously demonstrated by complementation of the avirulent type III strain, and it also
raises the question of the importance of evasion of the IRG system. Sibley and colleagues
also found that although the RHROP18 KO had a delayed time-till-death phenotype, it was
still 100% lethal (Behnke et al., 2011). It should be noted, however, that ROP18 was
knocked out in the RH type I strain while the QTL analysis of virulence was performed
using the GT1 type I strain. It was recently noted that these strains behave quite differently;
RH has a faster duplication time, it survives much better extracellularly and a significant
number of parasite genes is differentially expressed compared with GT1 (Khan et al.,
2009a). It would therefore be interesting to remove ROP18 in the GT1 background and
investigate its virulence phenotype.
Although the ROPK family pseudokinases are not expected to directly phosphorylate target
proteins, they may play scaffolding roles in allosteric regulation of active kinases or
mediating kinase–substrate interactions (Zeqiraj and van Aalten, 2010). The crystal structure
of the LKB1-STRADα-MO25α ternary complex revealed the structural basis of how the
STRADα pseudokinase helps to maintain the LKB1 kinase in an active conformation.
LKB1 interacts as a pseudosubstrate with regions of STRADα that correspond to the
substrate binding site in active protein kinases (Zeqiraj et al., 2009). Consistent with this
theme, the substrate binding loops of ROP2 and ROP8 are well ordered and structurally
conserved between the 3DZO and 3BYV crystal structures. However, differences in the
surface electrostatic potentials in the ROP2 (partly neutral and negative) and ROP8 (highly
positively charged) pseudosubstrate binding regions suggest different ligand specificities
(Qiu et al., 2009).
3.5. Toxoplasma rhoptry kinase ROP38 modulated MAPK signalling
After analysing the complete Toxoplasma kinome, Roos and colleagues further
characterised the ROP38 gene for the following reasons: it was predicted to be an active
kinase, it was differentially expressed between strains (up >64 fold in type III; >8 fold in
type II compared with type I), it was induced upon differentiation from tachyzoites to
bradyzoites, it was triplicated in both Toxoplasma and Neospora, and there was evidence for
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convergent evolution of Toxoplasma ROP38 and its Neospora homologue (Peixoto et al.,
2010). Because its expression is very low in type I strains they decided to study its function
by over-expressing HA-tagged type I ROP38 using a tubulin promoter in a type I strain.
HA-tag staining of infected cells confirmed co-localisation of ROP38 with ROP2, indicating
that it is indeed a rhoptry protein. ROP38 was also observed on the PVM, which contrasts
with a previously published report that it does not traffic to the PVM (ROP38 corresponds to
ROP2L5 in that paper) (Reese and Boothroyd, 2009). It is possible that the over-expression
of ROP38 resulted in mislocalisation and definitive localisation will depend on staining with
an antibody recognising endogenous ROP38. To determine if ROP38, like ROP16,
modulates host cell gene expression, host microarrays were performed after infection with
type I + ROP38I or wild-type type I. Interestingly, expression of the ROP38 transgene was
able to suppress a large proportion of genes that are normally regulated by type I infection.
Preliminary experiments suggested that ROP38 might modulate the MAPK pathway, as the
kinetics of ERK phosphorylation were different in type I-infected versus type I + ROP18I
infected cells. However, this difference in the modulation of host gene expression seemed to
have no consequences for virulence in mice as type I over-expressing ROP38 was as
virulent as wild-type type I.
3.6. The Plasmodium kinome
The P. falciparum kinome has been reported to comprise 85 or 99 enzymes, depending on
the stringency applied for inclusion of borderline sequences (Ward et al., 2004; Anamika
and Krupa, 2005). Both studies concur to present a picture of the Plasmodium kinome as
being characterised by significant divergences from the yeast or metazoan kinomes
(reviewed in Doerig and Meijer (2007) and Doerig et al. (2010).
Most established ePK groups have members in Plasmodium, although TyrK (tyrosine
protein kinases) and STEs (a group of PKs involved in mitogen-activated protein kinase
(MAPK) pathways) are not represented. The Plasmodium kinome comprises two atypical
MAPKs, but the absence of typical MAPKKs suggests that activity of these two enzymes is
regulated in a way that differs from that found in classical eukaryotic MAPK pathways.
These atypical MAPKs are but an example of a number of plasmodial PKs that can be
classified as belonging to established ePK families, but cannot be assigned precise orthology
with specific mammalian enzymes (for examples, see Dorin et al. (1999, 2001), Reininger et
al. (2005, 2009, 2011), Fennell et al. (2009), Abdi et al. (2010), Halbert et al. (2010),
Agarwal et al. (2011)). The Plasmodium kinome also includes many enzymes that do not
cluster with any of the PK groups and families established from the yeast and mammalian
kinomes, such as the FIKK kinases, which are specific to apicomplexan parasites (Schneider
and Mercereau-Puijalon, 2005), and the CDPKs (see above). Interestingly, individual PKs
displaying sequence features that are characteristic of distinct ePK groups are found in the P.
falciparum kinome, illustrating its evolutionary divergence from other kinomes (Bracchi-
Ricard et al., 2000; Dorin et al., 2001, 2005). A notable example of such “composite
kinases” is Pfnek-1, which has a clear relatedness to the NIMA family despite the presence
of a MAPKK-like putative activation site (Dorin et al., 2001).
A systematic kinome-wide knockout approach in P. berghei (Tewari et al., 2010) identified
several PKs as essential for development in the mosquito (genetic manipulations are
significantly more straightforward in the rodent malaria P. berghei than in P. falciparum,
because (i) gene replacement by double cross-over occurs at a much higher rate in the
former than in the latter, and (ii) the selection of transformed parasites occurs in the mouse
and is much faster than the in vitro cultivation of P. falciparum (Carvalho and Menard,
2005)). A similar study has recently addressed essentiality of 62 of the 65 P. falciparum
ePKs (this study excluded the FIKKs, see above). The inability to knockout a given locus,
together with the ability to modify the allele in a way that does not cause loss-of-function of
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the gene product (e.g. tagging the C-terminal end with HA epitopes or with GFP), is
interpreted as strongly indicative of an essential role of that locus during schizogony. Thirty-
six kinases were thus identified as playing a crucial role in erythrocytic schizogony, while
26 are most likely dispensable for this part of the life cycle (with cloned parasite lines
having thus far been obtained for 12 of these) (Solyakov et al., 2011).
3.6.1. Plasmodium exported kinases—Plasmodium expresses a set of unique kinases,
the FIKKs (Ward et al., 2004), 16 of which are predicted to be exported into the RBC due to
the presence of a PEXEL motif in their N-terminal region (Schneider and Mercereau-
Puijalon, 2005). The roles played by FIKK in the RBC are much less well understood than
those of some of the ROPKs in Toxoplasma-infected cells discussed above. We know that a
significant subset of FIKKs are indeed exported into the RBC shortly following parasite
invasion (Nunes et al., 2007, 2010) and that at least one member of the family remains
within the parasite, despite possessing a recognisable PEXEL (Nunes et al., 2007). Most fikk
genes are located in the sub-telomeric regions of 10 of the 14 chromosomes in P. falciparum,
in the vicinity of the var genes that mediate cytoadherence and antigenic variation. The var
genes are under allelic exclusion control, with a single PfEMP1 (var-encoded) protein
expressed at a time; this appears not to be the case for the fikk genes. Interestingly, however,
expression of a subset of fikk genes was modulated in parasites undergoing a switch in their
cytoadherence phenotype (Nunes et al., 2007). Knockout studies implicated two FIKKs in
the remodelling of the RBC membrane skeleton, as distinct phosphorylation profiles in ghost
preparations of parasite-infected RBCs were detected for each of the knockout parasite
clones (Nunes et al., 2010). In addition to FIKKs, a number of Plasmodium kinases have
been reported to be exported into the RBC (Kun et al., 1997; Droucheau et al., 2004; Vaid et
al., 2010) or even secreted to the extracellular milieu (Singh et al., 2009).
Recent data demonstrate that infection with malaria parasites causes a dramatic activation of
a signalling pathway involving host RBC PAK and MEK kinases, and that pharmacological
interference with these enzymes using highly selective allosteric inhibitors is lethal for the
parasite (Sicard et al., 2011). The parasite is also known to interfere with host cell signalling
in the liver stages (reviewed in Luder et al. (2009)), resulting in down-regulation of the
NFκB pathway (Singh et al., 2007) and in prevention of apoptosis of host hepatocytes (van
de Sand et al., 2005).
4. Conclusion
Thus, it appears that in both Toxoplasma and Plasmodium, two apicomplexan parasites that
are phylogenetically widely divergent from each other (Kuo et al., 2008), calcium-regulated
protein phosphorylation mediated by CDPKs plays central roles in regulating their entry into
and egress from the host and other developmental processes, and that both parasites export
proteins into their host cell to tailor it to their own needs. The secretion of virulence factors
into the host is a strategy widely used not only by the Apicomplexa (a striking further
apicomplexan-based example of this concept is the reversible transformation of leucocytes
by Theileria (reviewed in Shiels et al. (2006)), but also by many, if not all, intracellular
parasites (reviewed in Munter et al. (2006)). This not only provides a fascinating
fundamental glimpse into unique signalling mechanisms operating within parasites and
between parasites and their hosts, but also suggests opportunities for novel therapeutic
intervention.
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Comparative schematic of activation of Toxoplasma gondii calcium-dependent protein
kinases (CDPKs) and calmodulin-dependent kinases (CaMKs). The green lines represent the
auto-inhibitory region. CaM, Calmodulin; CAD, CDPK-activating domain. See Section 2
for details. [Reprinted from Doerig and Billker (2010) with permission from Macmillan
Publishers Ltd]
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The Toxoplasma kinome. Classification of 108 active kinases predicted from the
Toxoplasma gondii genome. Black, human and yeast; blue, Plasmodium falciparum; red, T.
gondii. Coloured arcs highlight major kinase groups: AGC, CMGC, CAMK, TKL, CK1 and
STE. Red lettering, apicomplexan-specific groups ROPK (pink) and FIKK. Red circles,
kinases with predicted secretory signal sequence or signal anchor (open, newly recognised);
black dots, bootstrap support >50%. [Reprinted from Peixoto et al. (2010) with permission
from Elsevier.]
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